Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 44,133 | 40,003 | 32,384 | 33,079 | 37,839 |
| Cost of Goods | 19,059 | 16,517 | 12,477 | 15,047 | 14,026 |
| Gross Profit | 25,074 | 23,486 | 19,907 | 18,032 | 23,813 |
| Operating Expenses | 19,035 | 18,153 | 17,342 | 19,450 | 18,272 |
| Operating Income | 6,098 | 5,850 | 3,042 | -1,371 | 5,567 |
| Interest Expense | 977 | 782 | 967 | 1,061 | 1,079 |
| Other Income | -15 | -72 | 100 | 76 | 207 |
| Pre-tax Income | 5,106 | 4,996 | 2,175 | -2,356 | 4,695 |
| Net Income Continuous | 51,386 | 4,996 | 2,175 | -2,356 | 4,695 |
| Net Income | $51,386 | $4,996 | $2,175 | $-2,356 | $4,695 |
| EPS Basic Total Ops | 0.31 | 0.03 | 0.01 | -0.01 | 0.02 |
| EPS Basic Continuous Ops | 0.31 | 0.03 | 0.01 | -0.01 | 0.03 |
| EPS Diluted Total Ops | 0.30 | 0.03 | 0.01 | -0.01 | 0.02 |
| EPS Diluted Continuous Ops | 0.30 | 0.03 | 0.01 | -0.01 | 0.03 |
| EPS Diluted Before Non-Recurring Items | 0.03 | 0.03 | 0.01 | N/A | N/A |
| EBITDA(a) | $6,995 | $6,448 | $3,604 | $-801 | $6,208 |